Preferred Label : Pegylated Liposomal Irinotecan;

NCIt synonyms : Liposomal Irinotecan;

NCIt definition : A formulation of polyethylene glycol (PEG)-modified liposomes encapsulating the semisynthetic derivative of camptothecin irinotecan, with antineoplastic activity. As a prodrug, irinotecan is converted to the biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. In turn, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex of topoisomerase I and DNA, resulting in DNA breaks. This results in an inhibition of DNA replication and an induction of apoptosis. Pegylated liposomal delivery of irinotecan improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of exposure while lowering systemic toxicity.;

Molecule name : IHL-305;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Metastatic Pancreatic Adenocarcinoma
neoplasm metastasis
Pegylated Liposomal Irinotecan
Pegylated Liposomal Irinotecan
liposomes
pancreatic neoplasms
irinotecan sucrosofate
irinotecan sucrosofate
antineoplastic agents
antineoplastic agents
pregnancy
breast feeding
drug interactions
antineoplastic combined chemotherapy protocols
fluorouracil
leucovorin
Fluorouracil/Liposomal Irinotecan/Leucovorin Regimen
orphan drug production
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
aged
DNA topoisomerases, type I
survival analysis
drug evaluation, preclinical
drug approval
europe
Irinotecan hydrochloride trihydrate (substance)
adult
adenocarcinoma
camptothecin
camptothecin
drug combinations
sucrose
sucrose
camptothecin
drug combinations
sucrose

---
http://www.has-sante.fr/portail/jcms/c_2757888/fr/onivyde
https://www.has-sante.fr/portail/jcms/c_2757888/fr/onivyde-irinotecan-liposomal-pegyle-antineoplasique
2017
false
false
false
France
French
treatment outcome
irinotecan
adult
neoplasm metastasis
pancreatic neoplasms
adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
antineoplastic combined chemotherapy protocols
antineoplastic agents, phytogenic
antineoplastic agents, phytogenic
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
evaluation of the transparency committee
fluorouracil
leucovorin
disease progression
survival analysis
Pegylated Liposomal Irinotecan
guidelines for drug use
camptothecin
Irinotecan
Irinotecan

---
Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.